Open access
Open access
Powered by Google Translator Translator

Dermatology

Review | Monkeypox.

27 Oct, 2022 | 12:36h | UTC

Monkeypox – New England Journal of Medicine

Related:

Diagnosis and Management of Monkeypox: A Review for the Emergency Clinician – Annals of Emergency Medicine

Monkeypox: disease epidemiology, host immunity and clinical interventions.

Monkeypox: A clinical update for paediatricians – Journal of Pediatrics and Child Health

Cohort Study | Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain.

CDC Report | Epidemiologic and clinical characteristics of Monkeypox cases in the US.

Update on the Monkeypox Outbreak – JAMA

Antivirals with Activity Against Monkeypox: A Clinically Oriented Review – Clinical Infectious Diseases

Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series – The BMJ

WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak – Health Policy Watch

Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022 – New England Journal of Medicine

Monkeypox: A Contemporary Review for Healthcare Professionals – Open Forum Infectious Diseases

 

Commentary on Twitter

 


Two Phase 3, randomized, controlled trials of Ruxolitinib cream for vitiligo.

21 Oct, 2022 | 13:03h | UTC

Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Ruxolitinib Cream Results in Greater Repigmentation in Vitiligo – HealthDay

 


Cohort Study | Use of straighteners and other hair products and incident uterine cancer.

20 Oct, 2022 | 12:28h | UTC

Use of Straighteners and Other Hair Products and Incident Uterine Cancer – JNCI: Journal of the National Cancer Institute

News Release: Hair straightening chemicals associated with higher uterine cancer risk – NIH News Releases

Commentaries:

Hair-straightening chemical products linked to increased uterine cancer risk in new study – CNN

Hair straightening chemicals may increase women’s risk of uterine cancer, study finds – NPR

 


Safety of Upadacitinib in moderate-to-severe atopic dermatitis: an integrated analysis of phase 3 studies.

19 Oct, 2022 | 14:14h | UTC

Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies – Journal of Allergy and Clinical Immunology

Related: Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical Trials – JAMA Dermatology

 


M-A | Incidence of cutaneous adverse events with Phosphoinositide 3-Kinase inhibitors as adjuvant therapy in patients with cancer.

14 Oct, 2022 | 14:01h | UTC

Incidence of Cutaneous Adverse Events With Phosphoinositide 3-Kinase Inhibitors as Adjuvant Therapy in Patients With Cancer: A Systematic Review and Meta-analysis – JAMA Oncology (free for a limited period)

 


M-A | Complications of hidradenitis suppurativa after surgical management.

13 Oct, 2022 | 13:40h | UTC

Complications of hidradenitis suppurativa after surgical management: A systematic review and meta-analysis – International Wound Journal

Commentary: Assessing Surgical Complications in Management of Hidradenitis Suppurativa – AJMC

 


RCT | Intravenous immune globulin reduces disease activity in dermatomyositis.

6 Oct, 2022 | 13:48h | UTC

Trial of Intravenous Immune Globulin in Dermatomyositis – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries:

NEJM: trial of IVIG for autoimmune disorder dermatomyositis – MedicalResearch.com

IV Immune Globulin Bests Placebo for Dermatomyositis – Drugs.com

 


M-A | Efficacy and safety of JAK inhibitors in the treatment of psoriasis and psoriatic arthritis.

6 Oct, 2022 | 13:37h | UTC

Efficacy and safety of JAK inhibitors in the treatment of psoriasis and psoriatic arthritis: a systematic review and meta-analysis – BMC Rheumatology

 


WAO/EAACI guideline for the management of hereditary angioedema.

4 Oct, 2022 | 14:34h | UTC

The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update – Allergy

 


AAP Clinical Report | Controlling and treating head lice in children and adolescents.

3 Oct, 2022 | 14:04h | UTC

Head Lice – Pediatrics

News Release: American Academy of Pediatrics Updates Report on Controlling and Treating Head Lice in Children, Adolescents – American Academy of Pediatrics

 


Systematic Review | Laser therapy for treating hypertrophic and keloid scars – not enough evidence to guide recommendations.

30 Sep, 2022 | 12:27h | UTC

Laser therapy for treating hypertrophic and keloid scars – Cochrane Library

Summary: Laser therapy for hypertrophic and keloid scars – Cochrane Library

 


RCT | Early initiation of short-term emollient use for the prevention of atopic dermatitis in high-risk infants.

28 Sep, 2022 | 13:35h | UTC

Early initiation of short-term emollient use for the prevention of atopic dermatitis in high-risk infants—The STOP-AD randomised controlled trial – Allergy

Commentary: Early Use of Short-term Emollients Linked With Reduced Incidence of AD in High-risk Infants – AJMC

 

Commentary on Twitter

 


Diagnosis and management of Monkeypox: a review for the emergency clinician.

26 Sep, 2022 | 12:07h | UTC

Diagnosis and Management of Monkeypox: A Review for the Emergency Clinician – Annals of Emergency Medicine

Related:

Monkeypox: disease epidemiology, host immunity and clinical interventions.

Monkeypox: A clinical update for paediatricians – Journal of Pediatrics and Child Health

Cohort Study | Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain.

CDC Report | Epidemiologic and clinical characteristics of Monkeypox cases in the US.

Update on the Monkeypox Outbreak – JAMA

Antivirals with Activity Against Monkeypox: A Clinically Oriented Review – Clinical Infectious Diseases

Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series – The BMJ

WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak – Health Policy Watch

Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022 – New England Journal of Medicine

Monkeypox: A Contemporary Review for Healthcare Professionals – Open Forum Infectious Diseases

 


RCTs | Effect of Roflumilast cream vs. vehicle cream on chronic plaque psoriasis.

22 Sep, 2022 | 13:06h | UTC

Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials – JAMA (free for a limited period)

Editorial: Roflumilast for Chronic Plaque Psoriasis – JAMA

Commentary: Study Suggests Roflumilast May Be Effective As Treatment For Plaque Psoriasis – HCPLive

 

Commentary on Twitter

 


RCT | Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis.

20 Sep, 2022 | 13:20h | UTC

Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial – The Lancet

Commentary: Dupilumab Eases Atopic Dermatitis in Children Younger Than 6 Years – HealthDay

 


RCT | Deucravacitinib vs. placebo and Apremilast in moderate to severe plaque psoriasis.

20 Sep, 2022 | 13:16h | UTC

Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 POETYK PSO-2 trial – Journal of the American Academy of Dermatology

 


RCT | Effect of different itraconazole dosing regimens on cure rates, treatment duration, safety, and relapse rates in adult patients with tinea corporis/cruris.

15 Sep, 2022 | 13:10h | UTC

Effect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris: A Randomized Clinical Trial – JAMA Dermatology (free for a limited period)

 

Commentary on Twitter

 


Monkeypox: disease epidemiology, host immunity and clinical interventions.

11 Sep, 2022 | 22:54h | UTC

Monkeypox: disease epidemiology, host immunity and clinical interventions – Nature Reviews Immunology

 

Commentary on Twitter

 


European guideline (EuroGuiDerm) on atopic eczema – Part II | Non-systemic treatments and treatment recommendations for special AE patient populations.

5 Sep, 2022 | 14:32h | UTC

European guideline (EuroGuiDerm) on atopic eczema – part II: non-systemic treatments and treatment recommendations for special AE patient populations – Journal of the European Academy of Dermatology and Venereology

Related: European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy – Journal of the European Academy of Dermatology and Venereology

 


Reports of asymptomatic monkeypox suggest that, at the very least, some infections go unnoticed.

1 Sep, 2022 | 11:54h | UTC

Reports of Asymptomatic Monkeypox Suggest That, at the Very Least, Some Infections Go Unnoticed – JAMA

 


RCT | Optical coherence tomography vs. punch biopsy for diagnosis of basal cell carcinoma.

31 Aug, 2022 | 11:31h | UTC

Optical coherence tomography versus punch biopsy for diagnosis of basal cell carcinoma: a multicentre, randomised, non-inferiority trial – The Lancet Oncology (link to abstract – $ for full-text)

News Release: 66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics’ VivoSight OCT laser scanner – PR Newswire

 


Monkeypox: a clinical update for pediatricians.

24 Aug, 2022 | 14:19h | UTC

Monkeypox: A clinical update for paediatricians – Journal of Pediatrics and Child Health

Related:

Cohort Study | Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain.

CDC Report | Epidemiologic and clinical characteristics of Monkeypox cases in the US.

Update on the Monkeypox Outbreak – JAMA

Antivirals with Activity Against Monkeypox: A Clinically Oriented Review – Clinical Infectious Diseases

Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series – The BMJ

WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak – Health Policy Watch

Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022 – New England Journal of Medicine

Monkeypox: A Contemporary Review for Healthcare Professionals – Open Forum Infectious Diseases

 


M-A of randomized trials | Risk of cutaneous adverse events in cancer patients treated with phosphatidylinositol-3-kinase inhibitors.

24 Aug, 2022 | 14:12h | UTC

Risk of cutaneous adverse events in cancer patients treated with phosphatidylinositol-3-kinase inhibitors: A systematic review and meta-analysis of randomized controlled trials – Cancer Medicine

 


Clinical practice guidelines for the management of atopic dermatitis.

24 Aug, 2022 | 14:13h | UTC

English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021 – The Journal of Dermatology

 


European guideline on atopic eczema – Part I: systemic therapy.

19 Aug, 2022 | 16:14h | UTC

European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy – Journal of the European Academy of Dermatology and Venereology

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.